Omega-3 May Indirectly Reduce Hepatocyte Triglycerides Through Modulation of Hyperinsulinemia, Cytokines and Adipocytokines

American Journal of Cardiology

Volumn 99, Issue 1, 2007, Pages 146-

  Shapiro, Haim ^a   Bruck, Rafael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; FATTY ACID; I KAPPA B KINASE; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

CALORIC INTAKE; CYTOKINE PRODUCTION; ENZYME INHIBITION; FATTY ACID SYNTHESIS; FATTY LIVER; HYPERINSULINEMIA; IMMUNOMODULATION; INSULIN SENSITIVITY; LETTER; LIPID DIET; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOCYTES; CYTOKINES; FATTY ACIDS, OMEGA-3; HEPATOCYTES; HUMANS; HYPERINSULINISM; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; TRIGLYCERIDES;

EID: 33845700309     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.10.006     Document Type: Letter

References (11)

1. Davidson M.H. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 98 suppl (2006) 27i-33i
2. Zick Y. Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci STKE 2005 (2005) pe4
3. Browning J.D., and Horton J.D. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114 (2004) 147-152
4. Ginsberg H.N., Zhang Y.L., and Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 36 (2005) 232-240
5. Marchesini G., Marzocchi R., Agostini F., and Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 16 (2005) 421-427
6. Holness M.J., Smith N.D., Greenwood G.K., and Sugden M.C. Acute omega-3 fatty acid enrichment selectively reverses high-saturated fat feeding-induced insulin hypersecretion but does not improve peripheral insulin resistance. Diabetes 53 suppl (2004) S166-S171
7. Capanni M., Calella F., Centenaro G., Biagini M., Svegliati-Baroni G., Milani S., Raimondi L., Mugelli A., Surrenti C., and Casini A. Prolonged n-3 PUFA dietary supplementation improves fatty liver in patients with NAFLD. Aliment Pharmacol Ther 23 (2006) 1143-1151
8. Svegliati-Baroni G., Candelaresi C., Saccomanno S., Ferretti G., Bachetti T., Marzioni M., De Minicis S., Nobili L., Salzano R., Omenetti A., et al. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol 169 (2006) 846-860
9. Shoelson S.E., Lee J., and Goldfine A.B. Inflammation and insulin resistance. J Clin Invest 116 (2006) 1793-1801
10. Mishra A., Chaudhary A., and Sethi S. Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPARalpha-dependent pathway. Arterioscler Thromb Vasc Biol 24 (2004) 1621-1627
11. Zhao Y., Joshi-Barve S., Barve S., and Chen L.H. Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr 23 (2004) 71-78